← FDA Drug Approvals (Drugs@FDA)

ERYTHROMYCIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PADAGIS US · Approved 1996-07-03

Drug application

FDA Application #
ANDA064126
Application type
Abbreviated New Drug Application (Generic)
Brand name
ERYTHROMYCIN
Generic name
ERYTHROMYCIN
Active ingredients
ERYTHROMYCIN
Dosage form
SWAB
Route
TOPICAL
Marketing status
Prescription
Sponsor
PADAGIS US
Manufacturer
Padagis Israel Pharmaceuticals Ltd
First approval
1996-07-03

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown